Phosphorus-containing inhibitors of endothelin converting enzyme: effects of the electronic nature of phosphorus on inhibitor potency.
Bertenshaw
S R
SR
Monsanto Corporate Research, St. Louis, Missouri 63167.
Rogers
R S
RS
Stern
M K
MK
Norman
B H
BH
Moore
W M
WM
Jerome
G M
GM
Branson
L M
LM
McDonald
J F
JF
McMahon
E G
EG
Palomo
M A
MA
D000818:Animals; D002851:Chromatography, High Pressure Liquid; D016232:Endothelins / Q000037:antagonists & inhibitors*; D006020:Glycopeptides / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D015260:Neprilysin / Q000037:antagonists & inhibitors*; D009943:Organophosphorus Compounds / Q000138:chemical synthesis* / Q000494:pharmacology; D011817:Rabbits; D013329:Structure-Activity Relationship
D016232:Endothelins; D006020:Glycopeptides; D009943:Organophosphorus Compounds; D015260:Neprilysin; C008890:phosphoramidon